Avadel Pharmaceuticals
AVDL
#5861
Rank
NZ$1.45 B
Marketcap
$15.03
Share price
-1.31%
Change (1 day)
-42.46%
Change (1 year)

Earnings for Avadel Pharmaceuticals (AVDL)

Earnings in 2024 (TTM): -NZ$81.99 Million

According to Avadel Pharmaceuticals 's latest financial reports the company's current earnings are NZ$0.16 Billion. , an increase over its 2023 earnings that were of -NZ$0.28 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Avadel Pharmaceuticals from 1996 to 2024

Annual earnings

Year Earnings Change
2024 -NZ$85.23 Million-69.47%
2023 -NZ$0.28 Billion44.27%
2022 -NZ$0.2 Billion19.64%
2021 -NZ$0.17 Billion1732.84%
2020 -NZ$8.83 Million-86.83%
2019 -NZ$67 Million-65.92%
2018 -NZ$0.2 Billion-222.16%
2017 NZ$0.16 B-1053.49%
2016 -NZ$16.88 Million-112.59%
2015 NZ$0.13 B-185.94%
2014 -NZ$0.16 Billion66.04%
2013 -NZ$93.94 Million582.16%
2012 -NZ$13.77 Million-7.6%
2011 -NZ$14.91 Million-2.1%
2010 -NZ$15.23 Million32.52%
2009 -NZ$11.49 Million-64.36%
2008 -NZ$32.24 Million-52.93%
2007 -NZ$68.47 Million5.66%
2006 -NZ$64.81 Million17.86%
2005 -NZ$54.98 Million-375.09%
2004 NZ$19.98 M-406.44%
2003 -NZ$6.53 Million-145.2%
2002 NZ$14.42 M-363.36%
2001 -NZ$5.48 Million-80.62%
2000 -NZ$28.28 Million132.68%
1999 -NZ$12.16 Million-50.34%
1998 -NZ$24.47 Million54.85%
1997 -NZ$15.81 Million-28.35%
1996 -NZ$22.06 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-NZ$31.53 Million-63.01%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$18 Million-78.89%๐Ÿ‡บ๐Ÿ‡ธ USA